Background Image
Table of Contents Table of Contents
Previous Page  173 / 658 Next Page
Information
Show Menu
Previous Page 173 / 658 Next Page
Page Background

3

Thermo Scienti c Poster Note

PN63780_E 03/13S

paration liquid chromatography

s and fluidics configuration to

pplications.

high efficiency HPLC utilizing core

etry were optimized for

e and steroidal compounds.

r while conserving consumables

) sample results from three

ferent locations typically varied by

have a need for rapid and

easy-to-use and maintain. We

l HPLC pump design and fluidics

mple cleanup using TurboFlow

phy (HPLC) on two channels

bility, linearity, and other

s (immunosuppressant drugs

min D and various steroids in

significantly reduced solvent

ble results.

d 20 uL injections of supernatants

TurboFlow column, transferred

mn (2.1 x 50 mm) in which the

ystem.

S) with heated electrospray ion

ective reaction monitoring (SRM)

PLC-MS system and to collect

to determine inter- and intra-

re 1). Using a test mix of four

mine, in both aqueous and

SPLC systems were tested.

as retention times across

epresentative Pressure Trace.

FIGURE 2. 500 Matrix Injections -

over 34 hrs of run time!

FIGURE 3. Peak Area %RSDs

Results

Whole-System Testing Verified Performance

To simulate a typical bio-analytical application, plasma spiked with our test mix was

mixed with a 3-fold volume of acetonitrile and centrifuged. To test the reproducibility

and ruggedness of the SPLC-MS/MS system, we ran a batch of 500 injections of the

supernatant, which had a duration of 34 hours. The peak retention times and areas for

each compound were reproducible as illustrated in Figure 2. Without the benefit of

smoothing or internal-standard compensation, peak area RSDs were below 9%

(Figure 3).

Inter-System Testing was Accep

While performance and ruggednes

single LC-MS system is essential, i

system performance is equally imp

The typical workflow from Develop

Production of a new method relies

system ruggedness and reproduci

this reason, data from three protot

SPLC systems were gathered over

course of 5 months of testing and r

time performance across the three

were analyzed. Reproducibility of r

times for each of the four test com

generated from both channels of t

systems is summarized in Figure

percent coefficient of variation (%C

values were calculated from A rand

selection of 9 data points for each

compound.

A Purpose-Built Method clearly

Knowing that a rigorous LC-MS m

test of the Prelude SPLC system,

chromatographic separations was

the first, Atenolol, the earliest elute

with the refocusing of analytes on t

shape differences in Warfarin and

may exist with gradient formation a

compositional mobile phase differe

degradation in peak shape if the m

prescribed by the method. In conc

The installation protocol for Prelud

pass 20 injections (10 per channel)

standard correction for retention ti

performance.

FIGURE 4. Retention Time Drift for four compounds over 34 hrs of run time

FIGURE 5. Pressure Trace Overlay across 34 hrs & Peak Overlay at injections

1,100, 200, 3 and 500

FIGURE 8. System Suitability ru

Pressure and Retention Times were Reproducible

While the reproducibility of raw area counts speaks to the removal of matrix effect and

its impact on data, the burden of 500 matrix injections and its impact on the aging of

the SPLC system and its columns can be significant. For that reason retention time

drift, pressure trace drift and peak shape changes were evaluated for the same data

set. As shown by Figures 4, 5 & 6, retention times, pressure traces and peak shapes

were remarkably stable throughout the 500-injection 34-hour batch.

mM ammonium formate + 0.05% formic acid

10 mM ammonium formate + 0.05% formic acid

nitrile + 45% isopropanol + 10% acetone

0

1

2

3

4

Time (min)

0

10

20

30

40

50

60

70

80

90

100

Relative Abundance

NL:

2.07E6

TIC MS

500injections

01

NL:

2.35E6

TIC MS

500injections

100

NL:

2.51E6

TIC MS

500injections

200

NL:

2.40E6

TIC MS

500injections

300

NL:

2.47E6

TIC MS

500injections

400

NL:

2.24E6

TIC MS

500injections

500

Imipramine

Lidocaine

Warfarin

Atenolol